SCHEMBL13637175

SCHEMBL13637175

C/N=C(\C)c1cc(O)c2ccc(OC)c(C)c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.40
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
MAPT P10636 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HSP90AA1 P07900 2/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
MMP14 P50281 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
PDE4D Q08499 3/20 0.33
HIF1A Q16665 1/20 0.33
EPAS1 Q99814 1/20 0.33
NPC1 O15118 1/20 0.32
NSD2 O96028 1/20 0.32
CASP6 P55212 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12070943 0.80 GPR35 (0.40) GPR35MEN1KMT2AMAPTKDM4E
SCHEMBL561626 0.80 GPR35 (0.47) GPR35MEN1KMT2AMAPTKDM4E
SCHEMBL14392924 0.76 GPR35 (0.44) GPR35MEN1KMT2AMAPTKDM4E
SCHEMBL6875131 0.74 MAPT (0.40) GPR35MEN1KMT2AMAPTKDM4E
SCHEMBL2624139 0.73 GPR35 (0.36) GPR35MEN1KMT2AMAPTKDM4E
SCHEMBL3627208 0.71 TDO2 (0.51) MEN1KMT2AMAPTKDM4EMAPK1
SCHEMBL1952047 0.71 USP2 (0.39) GPR35MEN1KMT2AMAPTKDM4E
SCHEMBL998408 0.70 ALDH1A1 (0.41) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL996497 0.69 CCR1 (0.42) MEN1KMT2AMAPTNPC1CYP1A2
SCHEMBL6877381 0.69 PDGFRB (0.36) GPR35ESR1ESR2PDE4DHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 WO disclosed